Labcorp (LH) EVP Diagnostics Bryan Vaughn discloses stock and RSU holdings

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Bryan T. Vaughn, EVP, Diagnostics, reported his initial equity holdings in the company. He directly beneficially owns 5,146.5702 shares of Labcorp common stock. He also holds several blocks of restricted stock units (RSUs), each representing the right to receive one share of common stock if vesting conditions are met.

These RSUs cover 178 shares vesting on February 7, 2026, 500 shares vesting on November 1, 2026, 360 shares vesting in two equal installments on February 6, 2026 and February 6, 2027, and 654 shares vesting in two equal installments on July 1, 2026 and July 1, 2027. Additional RSUs for 970 and 1,320 shares vest in three equal annual installments beginning February 11, 2026 and December 1, 2026, respectively.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vaughn Bryan T

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/04/2026

3. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Diagnostics

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,146.5702	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	(1)	Common Stock	178	(2)	D
Restricted Stock Unit	(3)	(3)	Common Stock	500	(2)	D
Restricted Stock Unit	(4)	(4)	Common Stock	360	(2)	D
Restricted Stock Unit	(5)	(5)	Common Stock	654	(2)	D
Restricted Stock Unit	(6)	(6)	Common Stock	970	(2)	D
Restricted Stock Unit	(7)	(7)	Common Stock	1,320	(2)	D

Explanation of Responses:

1. The Restricted Stock Units vest on February 7, 2026.

2. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

3. The Restricted Stock Units vest on November 1, 2026.

4. The Restricted Stock Units vest in two equal installments on February 6, 2026 and February 6, 2027.

5. The Restricted Stock Units vest in two equal installments on July 1, 2026 and July 1, 2027.

6. The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.

7. The Restricted Stock Units vest in three equal annual installments beginning on December 1, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Labcorp (LH) disclose in this Form 3 for Bryan T. Vaughn?

The filing shows that Bryan T. Vaughn, EVP, Diagnostics at Labcorp Holdings Inc., reports his beneficial ownership of common stock and multiple restricted stock unit (RSU) awards with specified vesting schedules.

How many Labcorp (LH) common shares does Bryan T. Vaughn directly own?

He directly beneficially owns 5,146.5702 shares of Labcorp common stock, reported as Common Stock, 5,146.5702, Direct (D) in the non-derivative securities table.

What restricted stock units (RSUs) are reported for Bryan T. Vaughn at Labcorp (LH)?

He reports RSUs covering 178, 500, 360, 654, 970, and 1,320 shares of Labcorp common stock. Each RSU represents the contingent right to receive one share of common stock upon vesting.

When do Bryan T. Vaughn’s Labcorp (LH) RSUs vest?

The filing states vesting dates and schedules: 178 RSUs vest on February 7, 2026; 500 RSUs vest on November 1, 2026; 360 RSUs vest in two equal installments on February 6, 2026 and February 6, 2027; 654 RSUs vest in two equal installments on July 1, 2026 and July 1, 2027; 970 RSUs vest in three equal annual installments beginning February 11, 2026; and 1,320 RSUs vest in three equal annual installments beginning December 1, 2026.

Is Bryan T. Vaughn a director or 10% owner of Labcorp (LH)?

No. The filing identifies him as an Officer with the title EVP, Diagnostics, and indicates he is not a director or a 10% owner of Labcorp Holdings Inc.

Are Bryan T. Vaughn’s Labcorp (LH) holdings reported as direct or indirect ownership?

All reported holdings in this filing, including the 5,146.5702 Labcorp common shares and all RSU awards, are listed with ownership form Direct (D), with no nature of indirect beneficial ownership disclosed.